12 Health Care Stocks Moving In Monday's After-Market Session
12 Health Care Stocks Moving In Monday's After-Market Session
週一盤後交易時段，12只醫療保健股走勢
Gainers
獲勝者
- Femasys (NASDAQ:FEMY) shares moved upwards by 56.8% to $0.52 during Monday's after-market session. This security traded at a volume of 461.0K shares come close, making up 12.7% of its average volume over the last 100 days. The company's market cap stands at $7.8 million.
- Pliant Therapeutics (NASDAQ:PLRX) stock rose 15.85% to $16.89. The company's market cap stands at $1.0 billion.
- Ontrak (NASDAQ:OTRK) stock moved upwards by 10.45% to $0.95. The company's market cap stands at $4.6 million.
- Brainstorm Cell (NASDAQ:BCLI) stock moved upwards by 9.42% to $0.47. This security traded at a volume of 566.4K shares come close, making up 202.2% of its average volume over the last 100 days. The market value of their outstanding shares is at $21.0 million.
- 180 Life Sciences (NASDAQ:ATNF) shares moved upwards by 8.65% to $0.65. The company's market cap stands at $3.8 million.
- Matinas BioPharma Hldgs (AMEX:MTNB) stock moved upwards by 7.84% to $0.13. The company's market cap stands at $29.2 million.
- Femasys 納斯達克股票代碼：FEMY）股價在週一的盤後交易時段上漲56.8％，至0.52美元。該證券的交易量爲46.10萬股，佔其過去100天平均交易量的12.7％。該公司的市值爲780萬美元。
- Pliant Therape 納斯達克股票代碼：PLRX）股價上漲15.85％，至16.89美元。該公司的市值爲10億美元。
- Ontrak 納斯達克股票代碼：OTRK）股價上漲10.45％，至0.95美元。該公司的市值爲460萬美元。
- 頭腦風暴細胞 納斯達克股票代碼：BCLI）股價上漲9.42％，至0.47美元。該證券的交易量爲56.64萬股，佔其過去100天平均交易量的202.2％。他們流通股的市值爲2,100萬美元。
- 180 生命科學 納斯達克股票代碼：ATNF）股價上漲8.65％，至0.65美元。該公司的市值爲380萬美元。
- 馬蒂納斯生物製藥控股公司 (AMEX: MTNB) 股價上漲7.84％，至0.13美元。該公司的市值爲2920萬美元。
Losers
失敗者
- TransCode Therapeutics (NASDAQ:RNAZ) stock declined by 20.0% to $2.04 during Monday's after-market session. This security traded at a volume of 15.7 million shares come close, making up 2625.3% of its average volume over the last 100 days. The market value of their outstanding shares is at $4.1 million.
- Biophytis (NASDAQ:BPTS) stock fell 8.18% to $1.46. At the close, Biophytis's trading volume reached 6.6 million shares. This is 1490.8% of its average volume over the last 100 days. The company's market cap stands at $7.8 million.
- NeuBase Therapeutics (NASDAQ:NBSE) stock decreased by 7.69% to $0.79. The market value of their outstanding shares is at $2.9 million.
- Tivic Health Systems (NASDAQ:TIVC) stock fell 5.48% to $1.9. The company's market cap stands at $2.7 million.
- Immix Biopharma (NASDAQ:IMMX) stock decreased by 5.44% to $2.8. The company's market cap stands at $45.5 million.
- Inozyme Pharma (NASDAQ:INZY) shares decreased by 4.88% to $4.1. The company's market cap stands at $253.0 million. See Also:
- TransCode 治療學 納斯達克股票代碼：RNAZ）股價在週一的盤後交易時段下跌20.0％，至2.04美元。該證券的交易量接近1,570萬股，佔其過去100天平均交易量的2625.3％。他們流通股的市值爲410萬美元。
- 生物植物 納斯達克股票代碼：BPTS）股價下跌8.18％，至1.46美元。收盤時，Biophytis的交易量達到660萬股。這是其過去100天平均交易量的1490.8％。該公司的市值爲780萬美元。
- NeuBase 療法 納斯達克股票代碼：NBSE）股價下跌7.69％，至0.79美元。他們流通股的市值爲290萬美元。
- Tivic 健康系統 納斯達克股票代碼：TIVC）股價下跌5.48％，至1.9美元。該公司的市值爲270萬美元。
- Immix Biophar 納斯達克股票代碼：IMMX）股價下跌5.44％，至2.8美元。該公司的市值爲4550萬美元。
- Inozyme 製藥 納斯達克股票代碼：INZY）股價下跌4.88％，至4.1美元。該公司的市值爲2.53億美元。 另請參閱：
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自動內容引擎生成，並由編輯審閱。